Occupational exposure to urinary bladder carcinogens - risk factors, molecular mechanisms and biomarkers. 2018

Marina Ruxandra Oţelea, and Viorel Jinga, and Alexandru Ştefan Cătălin Raşcu, and Iancu Emil Pleşea, and Amelia Nicoleta Petrescu, and Luminiţa Elena Mitrache, and Mihai Olteanu, and Dan Bondari, and Agripina Raşcu
Clinical Department 3, "Carol Davila" University of Medicine and Pharmacy, Department of Urology, "Prof. Dr. Theodor Burghele" Clinical Hospital, Bucharest, Romania; stefanrascu.sr@gmail.com.

Bladder cancer (BC) is one of the most frequent forms of cancer, particularly in Caucasian population. Many environmental factors are recognized as carcinogenic in humans for this form of neoplasia and some of them are related to occupation. In order to illustrate these effects, we have selected several relevant cases with smoking and occupational exposure to carcinogens and their histopathological findings. We reviewed the most important research published in the field of environmental-genomic interaction in relation with the oncogenesis of BC. Three main directions have been identified and described in the article: the environmental factors involved in BC pathogenesis and evolution, the molecular mechanisms involved in cell mitosis control and xenobiotic metabolism related to the qualitative and quantitative exposure and, finally, the possible biomarkers of the tumor evolution. From the genomic and proteomic research, new biomarkers emerged that are in the validation process. Immunohistochemical methods open also new perspectives to the diagnostic algorithms and could serve as prognosis biomarkers.

UI MeSH Term Description Entries
D001743 Urinary Bladder A musculomembranous sac along the URINARY TRACT. URINE flows from the KIDNEYS into the bladder via the ureters (URETER), and is held there until URINATION. Bladder,Bladder Detrusor Muscle,Detrusor Urinae,Bladder Detrusor Muscles,Bladder, Urinary,Detrusor Muscle, Bladder,Detrusor Muscles, Bladder
D002273 Carcinogens Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. Carcinogen,Oncogen,Oncogens,Tumor Initiator,Tumor Initiators,Tumor Promoter,Tumor Promoters,Initiator, Tumor,Initiators, Tumor,Promoter, Tumor,Promoters, Tumor
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012307 Risk Factors An aspect of personal behavior or lifestyle, environmental exposure, inborn or inherited characteristic, which, based on epidemiological evidence, is known to be associated with a health-related condition considered important to prevent. Health Correlates,Risk Factor Scores,Risk Scores,Social Risk Factors,Population at Risk,Populations at Risk,Correlates, Health,Factor, Risk,Factor, Social Risk,Factors, Social Risk,Risk Factor,Risk Factor Score,Risk Factor, Social,Risk Factors, Social,Risk Score,Score, Risk,Score, Risk Factor,Social Risk Factor
D014408 Biomarkers, Tumor Molecular products metabolized and secreted by neoplastic tissue and characterized biochemically in cells or BODY FLUIDS. They are indicators of tumor stage and grade as well as useful for monitoring responses to treatment and predicting recurrence. Many chemical groups are represented including HORMONES; ANTIGENS; amino and NUCLEIC ACIDS; ENZYMES; POLYAMINES; and specific CELL MEMBRANE PROTEINS and LIPIDS. Biochemical Tumor Marker,Cancer Biomarker,Carcinogen Markers,Markers, Tumor,Metabolite Markers, Neoplasm,Tumor Biomarker,Tumor Marker,Tumor Markers, Biochemical,Tumor Markers, Biological,Biochemical Tumor Markers,Biological Tumor Marker,Biological Tumor Markers,Biomarkers, Cancer,Marker, Biochemical Tumor,Marker, Biologic Tumor,Marker, Biological Tumor,Marker, Neoplasm Metabolite,Marker, Tumor Metabolite,Markers, Biochemical Tumor,Markers, Biological Tumor,Markers, Neoplasm Metabolite,Markers, Tumor Metabolite,Metabolite Markers, Tumor,Neoplasm Metabolite Markers,Tumor Markers, Biologic,Tumor Metabolite Marker,Biologic Tumor Marker,Biologic Tumor Markers,Biomarker, Cancer,Biomarker, Tumor,Cancer Biomarkers,Marker, Tumor,Markers, Biologic Tumor,Markers, Carcinogen,Metabolite Marker, Neoplasm,Metabolite Marker, Tumor,Neoplasm Metabolite Marker,Tumor Biomarkers,Tumor Marker, Biochemical,Tumor Marker, Biologic,Tumor Marker, Biological,Tumor Markers,Tumor Metabolite Markers
D016273 Occupational Exposure The exposure to potentially harmful chemical, physical, or biological agents that occurs as a result of one's occupation. Exposure, Occupational,Exposures, Occupational,Occupational Exposures
D044127 Epigenesis, Genetic A genetic process by which the adult organism is realized via mechanisms that lead to the restriction in the possible fates of cells, eventually leading to their differentiated state. Mechanisms involved cause heritable changes to cells without changes to DNA sequence such as DNA METHYLATION; HISTONE modification; DNA REPLICATION TIMING; NUCLEOSOME positioning; and heterochromatization which result in selective gene expression or repression. Epigenetic Processes,Epigenetic Process,Epigenetics Processes,Genetic Epigenesis,Process, Epigenetic,Processes, Epigenetic,Processes, Epigenetics

Related Publications

Marina Ruxandra Oţelea, and Viorel Jinga, and Alexandru Ştefan Cătălin Raşcu, and Iancu Emil Pleşea, and Amelia Nicoleta Petrescu, and Luminiţa Elena Mitrache, and Mihai Olteanu, and Dan Bondari, and Agripina Raşcu
August 1992, Environmental research,
Marina Ruxandra Oţelea, and Viorel Jinga, and Alexandru Ştefan Cătălin Raşcu, and Iancu Emil Pleşea, and Amelia Nicoleta Petrescu, and Luminiţa Elena Mitrache, and Mihai Olteanu, and Dan Bondari, and Agripina Raşcu
January 1993, IARC scientific publications,
Marina Ruxandra Oţelea, and Viorel Jinga, and Alexandru Ştefan Cătălin Raşcu, and Iancu Emil Pleşea, and Amelia Nicoleta Petrescu, and Luminiţa Elena Mitrache, and Mihai Olteanu, and Dan Bondari, and Agripina Raşcu
June 1997, Occupational and environmental medicine,
Marina Ruxandra Oţelea, and Viorel Jinga, and Alexandru Ştefan Cătălin Raşcu, and Iancu Emil Pleşea, and Amelia Nicoleta Petrescu, and Luminiţa Elena Mitrache, and Mihai Olteanu, and Dan Bondari, and Agripina Raşcu
January 1992, American journal of industrial medicine,
Marina Ruxandra Oţelea, and Viorel Jinga, and Alexandru Ştefan Cătălin Raşcu, and Iancu Emil Pleşea, and Amelia Nicoleta Petrescu, and Luminiţa Elena Mitrache, and Mihai Olteanu, and Dan Bondari, and Agripina Raşcu
March 2009, Occupational medicine (Oxford, England),
Marina Ruxandra Oţelea, and Viorel Jinga, and Alexandru Ştefan Cătălin Raşcu, and Iancu Emil Pleşea, and Amelia Nicoleta Petrescu, and Luminiţa Elena Mitrache, and Mihai Olteanu, and Dan Bondari, and Agripina Raşcu
June 2016, International journal of epidemiology,
Marina Ruxandra Oţelea, and Viorel Jinga, and Alexandru Ştefan Cătălin Raşcu, and Iancu Emil Pleşea, and Amelia Nicoleta Petrescu, and Luminiţa Elena Mitrache, and Mihai Olteanu, and Dan Bondari, and Agripina Raşcu
June 2001, Urological research,
Marina Ruxandra Oţelea, and Viorel Jinga, and Alexandru Ştefan Cătălin Raşcu, and Iancu Emil Pleşea, and Amelia Nicoleta Petrescu, and Luminiţa Elena Mitrache, and Mihai Olteanu, and Dan Bondari, and Agripina Raşcu
February 2008, Revue des maladies respiratoires,
Marina Ruxandra Oţelea, and Viorel Jinga, and Alexandru Ştefan Cătălin Raşcu, and Iancu Emil Pleşea, and Amelia Nicoleta Petrescu, and Luminiţa Elena Mitrache, and Mihai Olteanu, and Dan Bondari, and Agripina Raşcu
January 1994, IARC scientific publications,
Marina Ruxandra Oţelea, and Viorel Jinga, and Alexandru Ştefan Cătălin Raşcu, and Iancu Emil Pleşea, and Amelia Nicoleta Petrescu, and Luminiţa Elena Mitrache, and Mihai Olteanu, and Dan Bondari, and Agripina Raşcu
September 2013, American journal of industrial medicine,
Copied contents to your clipboard!